Confluence Pharmaceuticals
Carmel, US
Biotech
Founders & leadership
BW
Boyd W. Sturdevant, Jr.Manager of the Issuer
SL
Steven L. JohnsPresident, CEO and Manager of the Issuer
Reported raises · per SEC filings
Form D private placements$10KraisedOct 2018 · 1 investors · Pharmaceuticals
Rule 506(b)$1.3MraisedNov 2016 · 10 investors · Pharmaceuticals
Rule 506(c)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.